Tevogen Inc. Total Liabilities
Tevogen Inc. (TVGN) had Total Liabilities of $13.62 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-14
- 2026-06-30: Liabilities $13.62M.
- 2026-03-31: Liabilities $14.76M.
- 2025-12-31: Liabilities $12.62M.
- 2025-09-30: Liabilities $12.32M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $13.62M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $14.76M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $12.62M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $12.32M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $13.75M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $11.79M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $10.14M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $10.48M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $10.94M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $9.17M 10-Q · filed 2024-05-28 | |
| 2023-12-31 | $99.93M 10-K · filed 2025-04-02 | $17.73M 10-K · filed 2024-04-29 |
| 2023-09-30 | $16.56M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $16.25M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $15.43M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $15.06M 10-K · filed 2024-04-29 | |
| 2022-09-30 | $15.08M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $15.13M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $15.18M 10-Q · filed 2022-05-17 | |
| 2021-12-31 | $15.18M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $153.20K 10-Q · filed 2021-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |